Iovance Biotherapeutics Inc. (NASDAQ:IOVA) saw an upside of 1.43% to close Tuesday at $6.38 after adding $0.09 on the day. The 5-day average trading volume is 5,167,600 shares of the company’s common stock. It has gained $7.78 in the past week and touched a new high 1 time within the past 5 days. An average of 4,637,895 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 5,377,212.
IOVA’s 1-month performance is -13.43% or -$1.29 on its low of $6.00 reached on 08/21/23. The company’s shares have touched a 52-week low of $5.28 and high of $12.07, with the stock’s rally to the 52-week high happening on 05/23/23. YTD, IOVA has lost -0.16% or -$0.01 and has reached a new high 8 times. However, the current price is down -47.14% from the 52-week high price.
Valuation Metrics
IOVA stock has a beta of 0.11. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 8150.45 while the price-to-book (PB) in the most recent quarter is 2.47.
Iovance Biotherapeutics Inc.’s quick ratio for the period ended June 29 was 3.00, with the current ratio over the same period at 3.10.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income grew 6.74% to -$106.53 million, while revenue of -$107.37 million was -0.79% off the previous quarter. Analysts expected IOVA to announce -$0.8 per share in earnings in its latest quarter, but it posted -$0.47, representing a 41.30% surprise. EBITDA for the quarter stood at more than -$101.27 million. IOVA stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 178.72 million, with total debt at $80.71 million. Shareholders hold equity totaling $247.78 million.
Let’s look briefly at Iovance Biotherapeutics Inc. (IOVA) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 August was 37.49% to suggest the stock is trending Neutral, with historical volatility in this time period at 76.47%.
The stock’s 5-day moving average is $6.38, reflecting a -15.05% or -$1.13 change from its current price. IOVA is currently trading -10.01% above its 20-day SMA, -3.77% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -19.14% and SMA200 by-28.31%.
Stochastic %K and %D was 11.75% and 7.34% and the average true range (ATR) pointed at 0.45. The RSI (14) points at 39.21%, while the 14-day stochastic is at 19.69% with the period’s ATR at 0.44. The stock’s 9-day MACD Oscillator is pointing at -0.51 and -0.69 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Iovance Biotherapeutics Inc. (NASDAQ: IOVA), Wells Fargo upgraded it to an Overweight rating. They previously had an Equal weight rating on the stock. Analysts offering their rating for IOVA stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate IOVA as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 2 rates the stock as overweight while 10 have offered a “buy” rating.
What is IOVA’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $14.00 and a high of $40.00, with their median price target at $20.00. Looking at these predictions, the average price target given by analysts is for Iovance Biotherapeutics Inc. (IOVA) stock is $24.55.
